Pharmaceutical industry – Page 49

Business
Vertex to cut 370 jobs

2013-10-30T00:00:00Z

Imminent competition drives drop in its hepatitis C drug’s performance
Business
AstraZeneca to close environmental lab and cut 71 jobs

2013-10-25T00:00:00Z

Environmental impact services will be outsourced after Devon lab closes in March 2014
Business
Pharma manufacturing woes dog industry

2013-10-23T00:00:00Z

Regulators are stepping up inspections, and discovering ever more problems
Business
Counterfeit anxiety pills seized in Switzerland

2013-10-21T00:00:00Z

1 million fake tablets were en route from China to Egypt
Business
Roche backs biologics boom

2013-10-15T00:00:00Z

Swiss firm to invest heavily in manufacturing for complex biological drugs
Business
5000 jobs to be cut at Teva

2013-10-14T00:00:00Z

Generics giant aims to cut costs and reinvest in R&D
Business
GSK to apply for malaria vaccine approval

2013-10-09T00:00:00Z

Infection protection drops over time, but the firm will go ahead with regulatory submission
Business
Lundbeck cuts jobs in Europe, but expands in US

2013-10-04T00:00:00Z

Depression drug approval fuels US recruitment
Business
Amid huge cuts, Merck vows research focus

2013-10-04T00:00:00Z

8500 more jobs to be axed, but the drugmaker ‘remains committed to innovation’
Business
Aspen acquires anticoagulant brands

2013-10-02T00:00:00Z

South African drugmaker buys thrombosis drugs from GSK for £700m
Business
Japan confirms Novartis clinical trial data fabrication

2013-10-01T00:00:00Z

Investigation into blood pressure blockbuster continues
Business
New respiratory drugs neck and neck

2013-09-25T00:00:00Z

Combination inhalers from GSK and Novartis approved in EU and Japan
Business
Nanobody inflammation drug attracts Abbvie

2013-09-25T00:00:00Z

$840m licensing deal shows support for antibody fragments
Careers
Non-profit pharma

2013-09-24T00:00:00Z

Not-for-profit drug discovery is growing into a promising niche employment opportunity within the pharmaceutical industry. James Mitchell Crow investigates
Business
Service with a smile

2013-09-18T00:00:00Z

Company profile: Charnwood Molecular is more than a run-of-the-mill contract synthesis provider
Business
GSK criticised for trial data secrecy

2013-09-17T00:00:00Z

Italian research institute abandons collaboration over data access
Business
First biosimilar antibody drugs approved in Europe

2013-09-11T00:00:00Z

European commission gives final approval to generic infliximab copies
Business
Otsuka to buy Astex for $886 million

2013-09-06T00:00:00Z

Japanese firm intends to leave Astex’s fragment-based R&D efforts intact
Business
Amgen snaps up Onyx in huge biotech deal

2013-09-04T00:00:00Z

$10.4 billion acquisition will expand firm’s oncology portfolio
Business
Lundbeck appeals European antitrust fine

2013-09-03T00:00:00Z

Danish pharmaceutical claims €93.8 million pay-for-delay penalty was the result of ‘serious legal and factual errors’